Evidence map›Paper›PMID 30701385›Full record

ArticleLa Radiologia medica2019

Hybrid volumetric modulated arc therapy for whole breast irradiation: a dosimetric comparison of different arc designs.

Velayudham Ramasubramanian, Karunakaran Balaji, Sitaraman Balaji Subramanian, Krishnamoorthi Sathiya, Moorthi Thirunavukarasu, Chandrasekaran Anu Radha

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in La Radiologia medica, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Hybrid volumetric modulated arc therapy for hypofractionated radiotherapy of breast cancer: a treatment planning study.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2021
    Article
  6. Review
  7. Hybrid planning techniques for hypofractionated whole-breast irradiation using flattening filter-free beams.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Velayudham RamasubramanianSchool of Advanced Sciences, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India. vramasubramanian@vit.ac.in.ORCID http://orcid.org/0000-0002-4834-1141
Karunakaran BalajiSchool of Advanced Sciences, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India.ORCID http://orcid.org/0000-0002-1606-8769
Sitaraman Balaji SubramanianDepartment of Radiation Oncology, Gleneagles Global Hospitals, Chennai, India.
Krishnamoorthi SathiyaDepartment of Radiation Oncology, Gleneagles Global Hospitals, Chennai, India.
Moorthi ThirunavukarasuDepartment of Radiation Oncology, Gleneagles Global Hospitals, Chennai, India.
Chandrasekaran Anu RadhaSchool of Advanced Sciences, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo find an optimal arc design for hybrid volumetric modulated arc therapy (H-VMAT), a combination of conventional 3DCRT and VMAT plans for left-sided whole breast radiation therapy. METHODS AND MATERIALS: A total of 26 left-sided early-stage breast cancer patients were selected for this study. To find the superior plan, H-VMAT with three different arc designs including, two partial arcs (2A), four partial arcs (4A) and four tangential arcs (TA) were created for each study case by combining 3DCRT and VMAT with 75% 3DCRT/25% VMAT dose proportion of prescription dose.

resultsAll H-VMAT plans achieved the expected target coverage. A higher conformity index and homogeneity index were achieved for 2A and 4A H-VMAT plans and significantly differ from TA H-VMAT (p < 0.003). The heart and ipsilateral lung dose parameters were comparable among all plans except heart V

conclusion2A and 4A H-VMAT techniques are effective in improving the PTV dosimetric parameters as well as reducing the OAR doses. Further, 2A H-VMAT delivers less MU and beam-on time compared to 4A H-VMAT.

Indexed as

AdultAgedBreast NeoplasmsFemaleHumansMiddle AgedOrgans at RiskRadiometryRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedTreatment OutcomeBreast cancerHybrid-VMATVMATWhole breast

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.